2 In this 24-week study of sitagliptin 100 mg once daily in combination with glimepiride, the incidence of adverse reactions considered as drug-related in patients treated with sitagliptin/ glimepiride compared to treatment with placebo/ glimepiride was 11.3% and 6.6%, respectively.
2 Selles 24- nädalases uuringus, kus 100 mg sitagliptiini üks kord päevas kasutati kombinatsioonis glimepiriidiga, oli ravimiga seotud kõrvaltoimete esinemissagedus sitagliptiini/ glimepiriidi ja platseebo/ glimepiriidiga ravitud patsientidel vastavalt 11, 3% ja 6, 6%.